Saakshi Medtech and Panels, led by Aniket Vijay Latkar and Chitra Vijay Latkar, made a robust entry into the NSE SME platform on Tuesday. The company's shares registered a substantial premium of 50.5%, indicating a positive response from investors.
The company managed to raise Rs 45.16 crore ($6.08 million) through an initial public offering (IPO) that was oversubscribed 91.65 times. This successful IPO allowed Saakshi Medtech and Panels to issue a fresh batch of 46.56 lakh shares, further expanding its market presence.
The capital raised from the IPO will be employed for several purposes. A significant portion is earmarked for debt clearance, which will strengthen the company's financial standing. Additionally, funds will be allocated to maintain operational fluidity, ensuring the smooth functioning of the business.
The remainder of the capital will be directed towards other corporate agendas. While the specifics of these agendas were not disclosed, it is expected that they will involve strategic moves to enhance the company's market position and growth prospects.
This recent development underscores the potential of the NSE SME platform as a viable avenue for smaller companies to raise capital and grow their businesses. It also reflects investor confidence in Saakshi Medtech and Panels' business model and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.